Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

kelly smith

EU flag

Orphan drugs in latest CHMP recommendations

EMA advisers back new products from Genzyme, Boehringer and others

- PMLiVE

Novartis gets EU nod for rare disease drug Signifor

Long-acting formulation of drug approved for growth disorder acromegaly

- PMLiVE

EMA recommends two AbbVie treatments for hepatitis C

Exviera and Viekirax backed for use in Europe

- PMLiVE

AZ’s new COPD therapy gets green light in Europe

EC backs Duaklir in chronic respiratory condition

- PMLiVE

EMA appoints Luc Vanheel as head of administration

He joins with immediate effect

- PMLiVE

The behavioural science of adherence

A broad range of factors can influence a person’s decision not to take treatment as prescribed but these can now be seen to be underpinned by academic principles

- PMLiVE

Verona names David Ebsworth as non-executive chairman

He joins from Vifor Pharma

- PMLiVE

Astellas opens new office in Dubai

Will support operations in the Middle East, North and Sub-Saharan Africa

- PMLiVE

France agrees lowest Sovaldi pricing in EU

Government brings cost of hepatitis C drug to €5,000 below list price

- PMLiVE

Purdue gets FDA nod for abuse-deterrent painkiller

Around 105 people per day die from a drug overdose in the US

- PMLiVE

Stratified medicines face uptake challenges in the NHS

But 90% of HCPs believe the area will have a positive impact on the health system

UK flag

UK to review life sciences environment

Intends to speed up access to medicines and medical technologies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links